T0	Population 30720 30751	appropriate patient populations
T1	RelevantOutcomeExcluded 30756 30772	outcome measures
T2	VerySpecificPopulation 30869 30913	another subgroup of allergic asthma patients
T3	ExperimentalPhaseDuration 30925 30959	a treatment period beyond 36Â weeks
